» Authors » Nelly Mugo

Nelly Mugo

Explore the profile of Nelly Mugo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 153
Citations 3536
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
21.
Schuind A, Rees H, Schiller J, Mugo N, Dull P, Barnabas R, et al.
Prev Med Rep . 2023 Aug; 35:102331. PMID: 37576844
The burden of cervical cancer is disproportionately distributed globally, with the vast majority of cases occurring in low- and middle-income countries. Women with human immunodeficiency virus (HIV) (WWH) are at...
22.
Casmir E, Wairimu N, Kiptinness C, Oluoch L, Maina S, Walker K, et al.
medRxiv . 2023 Jul; PMID: 37503186
Background: The contraceptive vaginal ring (NuvaRing), one of the Multipurpose Prevention Technologies (MPT) products, is effective in preventing unintended pregnancies and may contribute to reducing the frequency of Bacterial Vaginosis...
23.
Mugwanya K, Palayew A, Schaafsma T, Irungu E, Bukusi E, Mugo N, et al.
J Int AIDS Soc . 2023 Jul; 26(7):e26137. PMID: 37403405
Introduction: Effective PrEP use is critical for impact, but data are limited on common patterns of continuation and coverage among persons using PrEP in real-world settings. Methods: Data are from...
24.
Milford C, Smith E, Ngure K, Thuo N, Newmann S, Lazarus N, et al.
Reprod Health . 2023 Jun; 20(1):87. PMID: 37309003
Background: Preterm birth (PTB) is a global health epidemic, sub-Saharan Africa is severely impacted due to its limited healthcare resources. Pregnancy knowledge, cultural beliefs and practices play a role in...
25.
Berard A, Brubaker D, Birse K, Lamont A, Mackelprang R, Noel-Romas L, et al.
Cell Rep . 2023 May; 42(5):112474. PMID: 37149863
Bacterial vaginosis (BV) is characterized by depletion of Lactobacillus and overgrowth of anaerobic and facultative bacteria, leading to increased mucosal inflammation, epithelial disruption, and poor reproductive health outcomes. However, the...
26.
Irungu E, Musau M, Nyerere B, Dollah A, Kwach B, Owidi E, et al.
PLOS Glob Public Health . 2023 Mar; 2(3):e0000092. PMID: 36962311
Delivery of oral PrEP, a potent HIV prevention intervention, has begun within public health systems in many countries in Africa. Training as many health providers as possible expeditiously is necessary...
27.
Velloza J, Roche S, Owidi E, Irungu E, Dollah A, Kwach B, et al.
J Int AIDS Soc . 2023 Feb; 26(2):e26055. PMID: 36739603
Introduction: HIV pre-exposure prophylaxis (PrEP) is an essential prevention strategy being scaled up for priority populations in Kenya, including for HIV serodiscordant couples. The COVID-19 pandemic posed challenges to PrEP...
28.
Zia Y, Mugo N, Ngure K, Odoyo J, Casmir E, Ayiera E, et al.
Front Reprod Health . 2022 Oct; 3:638013. PMID: 36303958
Unmet need for contraception, unintended pregnancy, and access to safe abortion remain global challenges preventing adolescent girls and young women (AGYW) from achieving optimal reproductive health. Furthermore, AGYW face difficulties...
29.
Rao D, Bayer C, Liu G, Chikandiwa A, Sharma M, Hathaway C, et al.
J Int AIDS Soc . 2022 Oct; 25(10):e26021. PMID: 36225139
Introduction: In settings with high HIV prevalence, cervical cancer incidence rates are up to six-fold higher than the global average of 13.1 cases per 100,000 women-years. To inform strategies for...
30.
Katz I, Ngure K, Kamolloh K, Ogello V, Okombo M, Thuo N, et al.
AIDS Behav . 2022 Aug; 27(1):106-118. PMID: 35930203
Few studies have focused on understanding pre-exposure prophylaxis (PrEP) non-initiation among young, high-risk women in sub-Saharan Africa. This study aimed to qualitatively explore why young women in Kenya at high-risk...